Business plan 2023 to 2024
Our Business Plan sets out our priorities for the business year 2023 to 2024.
Our Business Plan sets out our priorities for the business year 2023 to 2024.
Last month we held three more sector focused forums. Meeting together in this way has many benefits, as some of the things we talked about can illustrate.
We recently started a new programme of sector-focused stakeholder engagement forums starting with leaders from the Human Application, ODT, Anatomy and Post Mortem sectors, where the Terms of Reference were agreed. We’re looking forward to further forums later in the year.
The forums have three functions:
to provide a forum to discuss sector-focused regulatory issues
to consider regulatory policies and practice
to share relevant regulatory concerns, knowledge, insight, and intelligence.
Today, the Human Tissue Authority (HTA) has published an updated version of Code of Practice F, part two. The HTA undertook a review of the Code to reflect the introduction of deemed consent for deceased organ and tissue donation for the purpose of transplantation in Northern Ireland (NI).
The amendments made to the Code in relation to Northern Ireland will not apply until the Northern Ireland Deemed Consent Act comes into force.
Last week we kicked off our new programme of stakeholder events by hosting a roundtable with devolved administrations.